🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
QRL-101-03 is a multiple ascending dose (MAD) study to evaluate the safety,...
Status
Completed
Location
ICON plc. Van Swietenlaan 6
Start Date
2024-07-01
Trial ID
NCT06532396
QRL-101-08 is a multiple ascending dose (MAD) study to evaluate the safety,...
Status
Active Not Recruiting
Location
ICON plc.
Start Date
2026-02-02
Trial ID
NCT07421778
This is a phase I, prospective, single-center, randomized, double-blind, pl...
Status
Completed
Location
Centre for Human Drug Research
Start Date
2024-10-07
Trial ID
NCT06681441
Treatments Being Tested
This Phase 1 randomized, placebo-controlled, double-blind study will evalua...
Status
Completed
Location
Universitair Medisch Centrum Utrecht
Start Date
2024-11-11
Trial ID
NCT06714396
The purpose of this study is to evaluate the safety, tolerability, and phar...
Status
Completed
Location
ICON plc. Van Swietenlaan 6
Start Date
2022-12-22
Trial ID
NCT05667779
This study aims to evaluate the pharmacokinetics of three QRL-101 formulati...
Status
Completed
Location
ICON plc. Van Swietenlaan 6
Start Date
2025-01-10
Trial ID
NCT06877624
Treatments Being Tested